权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Manganese dioxide as a nanozyme to mitigate oxidative stress in osteoarthritis

二氧化锰作为纳米酶可减轻骨关节炎的氧化应激

基本信息

批准号：
10751638
负责人：
Jessica L Aldrich
金额：
$ 4.24万
依托单位：
UNIVERSITY OF FLORIDA
依托单位国家：
美国
项目类别：
财政年份：
2023
资助国家：
美国
起止时间：
2023-08-16 至 2025-08-15
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10751638
关键词：
Address Advanced Development Affect Antioxidants Arthralgia Behavior Binding Sites Biocompatible Materials Biological Availability Biological Factors Cartilage Characteristics Charge Chondrocytes Chronic Classification Clinic Contralateral Degenerative polyarthritis Development Disease Disease Progression Drug Delivery Systems Engineering Enzymes Etiology Evaluation Feedback Generations Histologic Homeostasis Hydrogen Peroxide In Vitro Inflammation Inflammatory Injury Interruption Joints Knee Injuries Laboratory Research Learning Limb structure Location Manganese Masks Measures Mitochondria Modeling Motivation Orthopedics Oxidation-Reduction Oxidative Stress Oxygen Pain Pathogenesis Pathology Peroxidases Persons Play Production Property Public Health Reactive Oxygen Species Research Rodent Rodent Model Role Signal Transduction Structure Superoxides Tactile Techniques Testing Therapeutic Therapeutic Agents Time Training Translating Traumatic Arthropathy Treatment Efficacy United States Water Work aging population antioxidant therapy arthropathies cartilage degradation catalase chondroprotection conventional therapy cost disability effective therapy gait examination improved in vivo inflammatory marker injured innovation insight joint destruction joint function joint injury metal oxide mitochondrial dysfunction nanomaterials nanoparticle nanoparticle delivery novel preservation prevent sensor small molecule targeted treatment therapeutic target training opportunity translational approach translational medicine translational potential uptake

项目摘要

PROJECT SUMMARY In this proposal, we aim to characterize the multi-enzymatic and chondroprotective functions of a bioactive biomaterial, manganese dioxide (MnO2) nanoparticles (NPs), as a therapeutic strategy to mitigate oxidative stress in osteoarthritis (OA). The motivation for this work is the critical need to address limitations for treating OA as a looming public health crisis, projected to affect 130 million people worldwide by 2050 due to an aging population. Oxidative stress, the imbalance between reactive oxygen species (ROS) generation and antioxidant function, is known to contribute to OA progression and may represent an important therapeutic target. There have been numerous studies to evaluate the use of antioxidants and small molecules as therapeutic agents, however these therapies are limited by poor bioavailability and stability within the joint. The objective of this proposal is to utilize a metal-oxide biomaterial (MnO2) to overcome limitations of retention and bioavailability and seeks to explore enzyme-mimicking functions to reduce the effects of oxidative stress. We have previously shown that MnO2 can be engineered with cartilage-targeting properties, such as size and charge, that can overcome limitations of traditional antioxidant therapies. Leveraging these properties we have seen improved retention of MnO2 NPs in healthy and OA joints. Due to the barriers for targeting cartilage, this advancement is critical in the development of a chondroprotective therapy. We hypothesize that MnO2 NPs possess enzyme mimicking properties that will reduce oxidative stress in the joint thereby alleviating pain and disease pathogenesis. Characterization of enzyme mimicking functions is critical in the use of MnO2 NPs for biomedical applications and may further classify the biomaterial as a ‘nanozyme.’ Our lab has already characterized the hydrogen peroxide scavenging properties of MnO2 NPs and we anticipate ‘nanozyme’ classification will outline catalase-like, superoxide-like, and peroxidase-like functions of MnO2. In Aim 1, we will examine how MnO2 NPs influence compartment specific H2O2 production and the downstream effects of oxidative stress. Specifically, we will characterize the antioxidant-like properties of MnO2 NPs and their impact on redox signaling, chondroprotection, and inflammatory effects. In Aim 2 we will evaluate the therapeutic efficacy of MnO2 NPs in vivo using a rodent model of post traumatic OA (PTOA) through comprehensive evaluation of NP retention in the joint, joint remodeling, and behavior. Immediate treatment following joint trauma, which leads to PTOA, is a critical opportunity for translation of a cartilage targeting therapy by leveraging cartilage that is still intact and may be responsive to mitigating oxidative stress. The proposed work is significant and innovative by revealing key mechanisms for mitigating oxidative stress and advancing the use of an enzyme-mimicking therapy that may facilitate translation of strategies to slow the progression of joint disease.

项目总结